Invictus MD Announces Completion of its Commitment to Acquire 33.33% of Licensed Producer AB Laboratories Inc.

Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

 

FOREX INVESSTORS  PRESS RELEASE  Acreage Pharms Ltd   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), Acreage Pharms Ltd. (“Acreage Pharms”) located near Edson, Alberta, utilizing a multi-room indoor perpetual growing methodology, will begin its first harvest the first week of August, with the second harvest occurring the following week.  The company anticipates a harvest to take place approximately monthly going forward.

Invictus MD is further pleased to announce that Acreage Pharms has received its development permit for Phase 2 and has broken ground initiating construction on its 27,800 square foot purpose built, multiple room production facility. All contractors and suppliers necessary for the project have been scheduled. Invictus MD has committed to investing $6.0 million, which will be used to fund the costs of constructing the production facility.

“Following our successful harvest at the AB Laboratories production facility as announced earlier, and by securing the development permit for our Alberta production facility, with $30 million cash available and the majority earmarked for building production capacity, Invictus MD is prepared for an exciting year of growth,” said Dan Kriznic, Executive Chairman and CEO, Invictus MD. “Led by one of the industry’s most experienced teams, we are strongly focused on building our shareholder value. With 250 acres of cultivation space that stretches from Alberta to Ontario, allowing for purpose built production facilities rather than retrofitting existing buildings, our large land package allows for building cultivation facilities as demand increases and we will continue the disciplined but agile execution of our business strategy, and further establishing our leadership position as Canada’s cannabis company” added Kriznic.



Acreage Pharms Ltd

Invictus MD also announced that Mr Paul Sparkes and Mr. Josef W. Hocher have been appointed to the Company’s Board of Directors.

Mr. Paul Sparkes is an accomplished business leader with over twenty five years’ experience in media, public affairs, venture capital, and Canada’s political arena. He is Currently President of Otterbury Holdings Inc., a corporation advising growth companies in the private and public markets.  Most recently Mr. Sparkes was Executive Vice Chair, Director and co-founder of Difference Capital Financial, a TSX-listed specialty finance company. Previously, Mr. Sparkes was Executive Vice President, Corporate Affairs for CTVglobemedia (now Bellmedia). Prior to joining Bell Globemedia in 2001 as Group Vice-President, Public Affairs, Mr. Sparkes held senior positions in public service, including with the Government of Canada and the Government of Newfoundland and Labrador. From 1996 to 2001, he served in the Office of the Prime Minister of Canada as Director of Operations, and Special Assistant for Atlantic Canada. Mr. Sparkes also served as Executive Assistant to two Premiers of Newfoundland and Labrador. Mr. Sparkes sits on several public and private boards including Thunderbird Entertainment (private), Bluedrop Performance Learning Inc. (TSXV: BPL), Antler Gold Inc (TSXV:ANTL.V) BlastGard International Inc (BLGA-US) and is a former board member of the Liquor Control Board of Ontario ( LCBO).

Mr. Josef W. Hocher was a founder of Buried Hill Energy, an international oil and gas company, where he acted as co-chief executive in creating, developing and implementing the organization’s strategic direction.  He continues to serve as the Senior Independent Director and is also either a Chair or a member of various committees. Mr. Hocher also founded Hitic Energy Ltd., and was a partner at Osler, Hoskin & Harcourt LLP. He currently serves as Chairman of Orthoshop Geomatics Ltd., a geomatics services company; holds the position of Chief Commercial Officer at Field Upgrading Limited and Western Hydrogen Limited and since 2016, has been a Partner at Cassels, Brock & Blackwell LLP.

About Invictus MD Strategies Corp.

Invictus MD Strategies Corp. is focused on two main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR, including its wholly owned subsidiary Acreage Pharms Ltd., as well as its investment in the fully licensed facility AB Laboratories Inc.; and Fertilizer and Nutrients through Future Harvest Development Ltd.

For more information, please visit www.invictus-md.com.

On Behalf of the Board,
Dan Kriznic
Executive Chairman & CEO

Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676

Cautionary Note Regarding Forward-Looking Statements: Statements contained in this news release that are not historical facts are “forward-looking information” or “forward-looking statements” (collectively, “Forward-Looking Information”) within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995. Forward Looking Information includes, but is not limited to, disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action; and the plans for completion of the Offering, expected use of proceeds and business objectives. In certain cases, Forward-Looking Information can be identified by the use of words and phrases such as “anticipates”, “expects”, “understanding”, “has agreed to” or variations of such words and phrases or statements that certain actions, events or results “would”, “occur” or “be achieved”. Although Invictus has attempted to identify important factors that could affect Invictus and may cause actual actions, events or results to differ materially from those described in Forward-Looking Information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended, including, without limitation, the risks and uncertainties related to the Offering not being completed in the event that the conditions precedent thereto are not satisfied. In making the forward-looking statements in this news release, Invictus has applied several material assumptions, including the assumptions that (1) the conditions precedent to completion of the Offering will be fulfilled so as to permit the Offering to be completed on or about June 1, 2017; (2) all necessary approvals will be obtained in a timely manner and on acceptable terms; and (3) general business and economic conditions will not change in a materially adverse manner. There can be no assurance that Forward-Looking Information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on Forward-Looking Information. Except as required by law, Invictus does not assume any obligation to release publicly any revisions to Forward-Looking Information contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )



BUZ INVESTORS Communauto, a car-sharing pioneer in North America, will move forward with the City of Montreal pilot project after receiving confirmation that its users will have access to a sufficient n

Communauto is continuing the development of its offer and “arrives in Ville (Marie)” with its electric car-electric vehicles

|Chart | Calendar   | TRADE NOW | ELECTRIC

Communauto is continuing the development of its offer and “arrives in Ville (Marie)” with its electric car-electric vehicles

BUZ INVESTORS Communauto, a car-sharing pioneer in North America, will move forward with the City of Montreal pilot project after receiving confirmation that its users will have access to a sufficient n

BUZ INVESTORS  Communauto, a car-sharing pioneer in North America, will move forward with the City of Montreal pilot project after receiving confirmation that its users will have access to a sufficient number of spaces to release their electric vehicle in Ville-Marie. In total, approximately 115 on-street parking distributed in about fifty drop points will be made available to electric vehicle car-sharing drivers.

Communauto’s fleet of vehicles already has 120 electric vehicles, of which 85 have been labelled Auto-mobile (free-floating without reservation), making it the second-largest self-service electric vehicle fleet in the Americas.

“Communauto has always decided to take the risk of innovating and this is what we are committed to do by electrifying part of our fleet of vehicles and integrating our two offers, with and without reservations, for the greatest pleasure of our users who benefit from the best of both worlds,” said Benoit Robert, CEO of Communauto. For this reason, Communauto’s overall offer will also be increased.

Over the next few weeks, approximately 300 new cars will be brought into service in Canada (Montreal, Quebec City, Ottawa, Halifax) and in France. 220 of these vehicles (models with hybrid engines) are destined for the Quebec market. In the province, the offer will increase from 1,750 to nearly 2,000 vehicles.



Communauto

>>>TRADE NOW<<<

From this number, 75 vehicles are destined for the free floating without reservation service, Auto-mobile, which will total 630 vehicles. This addition will make it possible to maintain the abundance of the offer despite the extension of the service area with the addition of the Villeray-Saint-Michel-Parc-Extension borough of the Saint-Michel sector. The Ahuntsic and Saint-Laurent boroughs are also part of the expansion areas desired by Communauto.

The 145 other vehicles that will be put into service will be used to improve the offer with a reservation now deploying in a dense network of nearly 500 stations located in the heart of the districts served. Communauto continues to build on its traditional offering with the opening of nearly twenty new stations in the cities of Montreal, Quebec City, Longueuil, Laval, Gatineau and Sherbrooke.

In Montreal, stations will be added in the Côte-St-Luc, Cartierville, Notre-Dame-de-Grâce, Île-des-Sœurs, Hochelaga and Montreal-Nord sectors.

On the South Shore, Communauto plans to open stations in Brossard (Mail Champlain) and Longueuil (OMHL); In Laval, two stations will be added to the network, one of which will be part of the Urbania real estate development project.

In Quebec City, new stations will be created in the St-Sauveur neighborhoods, Vieux-Limoilou, St-Roch, Montcalm and Vanier.

In Gatineau, in the Hull island sector, and in Sherbrooke, in the Fleurimont and Jacques-Cartier sectors.

Highlights of Communauto’s 2017 Development Plan

Development of the offer without reservation Auto-mobile:

  • The total number of Auto-mobile is increased to 630 of which 85 (14%) are 100% electric
  • Opening of 50 exclusive drop-off points for electric cars in Ville-Marie borough in Montreal

Development of the offer with reservation:

  • Communauto is continuing to build on its traditional offer with reservations, with the opening of nearly 20 stations to reach its subscribers in Montreal, Quebec City, Sherbrooke, Gatineau, Brossard and Longueuil

In total:

  • 300 vehicles added including 275 in Canada and 220 in Quebec
  • For its entire range, in Quebec, Communauto’s fleet went from 1750 to nearly 2000 vehicles, 120 of which were 100% electric and 1,300 hybrid engines. 72% of the park will now be hybrid or 100% electric.

About us

With its 22 years of existence, Communauto is a pioneer of car-sharing in North America. The social, environmental and urban development company offers two car-sharing services (Free floating and station based) and shares of its 2,000 vehicles. It has the largest fleet of free-floating electric vehicles in Canada. Communauto’s network is present in Quebec (Montreal, Quebec, Laval, Longueuil, Gatineau, Sherbrooke) in Nova Scotia (Halifax), Ontario (Ottawa, Kingston) and France (Paris).

Like up on FACEBOOK


logo

Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




BUZ INVESTORS PRESS RELEASE Technology-Enabled Spaces Steelcase and Microsoft Corp. have joined forces to explore the future of work, developing a range of technology- enabled spaces designed to help organizations foster creative thinking

Steelcase and Microsoft Announce Development of Technology-Enabled Spaces Designed to Boost Creative Work

|Chart | Calendar   | TRADE NOW | Microsoft

Steelcase and Microsoft Announce Development of Technology-Enabled Spaces Designed to Boost Creative Work

BUZ INVESTORS PRESS RELEASE Technology-Enabled Spaces    Steelcase and Microsoft Corp. have joined forces to explore the future of work, developing a range of technology- enabled spaces designed to help organizations foster creative thinking and better collaboration. These spaces seamlessly integrate the best of Microsoft Surface devices with Steelcase architecture and furniture. Today the companies unveiled five new âCreative Spacesâ showcasing how Steelcase and Microsoft can help organizations unlock creativity for every employee.

Photos accompanying this announcement are available at http://www.globenewswire.com/NewsRoom/AttachmentNg/d61a1308-51c6-4c34-ad29-6eec6a036c13

http://www.globenewswire.com/NewsRoom/AttachmentNg/e57257e1-1dcd-42c5-b177-3a70c3443c51

http://www.globenewswire.com/NewsRoom/AttachmentNg/064508dd-7125-4e6d-b70c-15cd38ea2066

http://www.globenewswire.com/NewsRoom/AttachmentNg/13b53c9a-8418-4afd-a02f-393317b825db

http://www.globenewswire.com/NewsRoom/AttachmentNg/0c537bf5-57ba-493b-bb45-6027ccc34db3

Additionally, Steelcase and Microsoft announced:

  • That Microsoft is expanding its partner network into the world of design by bringing in select Steelcase dealers as authorized Surface Hub resellers.
  • Steelcase and Microsoft are working together to develop technology-enabled workplace solutions built on Microsoft Azure IoT technology.




Technology-Enabled Spaces

>>>TRADE NOW<<<

âThe problems people face at work today are much more complex than they used to be. They require a new creative way of thinking and a very different work process,â says Sara Armbruster, vice president of strategy, research and new business innovation for Steelcase. âWe believe that everyone has the capacity for creative thinking, and people are happier doing creative, productive work. Together, Microsoft and Steelcase will help organizations thoughtfully integrate place and technology to encourage creative behaviors at work.â

The Problem: Fostering Creativity as a Business Advantage
According to joint research conducted by Steelcase and Microsoft, creativity is seen as a critical job skill driven by organizationsâ need for innovation and growth in addition to employeesâ desire for meaningful work. However, today many organizations invest in technology and space as separate entities rather than approaching them holistically. The lack of cohesion creates sub-optimal conditions for fostering creativity at work.

The research released today (of 515 US and Canadian companies with 100 employees)i reveals the pressure people feel about the shift toward more creative work:

  • Seventy-two percent of workers from diverse fields including Health Care, Retail, Education, Financial Services and Manufacturing believe their future success depends on their ability to be creative.
  • Seventy-six percent believe emerging technologies will change their jobs, requiring more creative skills as routine work becomes automated.
  • There is greater need to collaborate in business, yet only 25 percent of respondents feel they can be creative in the places they currently have available for group work.
  • The study also reveals the connection between creativity and privacy, as employees ranked having a place to work without disruption as the second highest factor that could improve creativity, just behind the need for more time to think.

Creative Spaces
The companiesâ exploration of creative work found that creativity is a process in which anyone can engage and requires diverse work modes as well as different types of technology. People need to work alone, in pairs and in different size groups throughout a creative process, and they need a range of devices that are mobile and integrated into the physical workplace. Additionally, spaces should inspire people without compromising performance.

âEvery Microsoft Surface device strives to enable the creator in each of us. Devices like Surface Studio and Surface Hub are fundamentally designed around how people naturally create, connect, and collaborate,â says Ryan Gavin, general manager, Microsoft Surface Marketing. âWith Steelcase we have the compelling opportunity to blend place and technology into a seamless environment that allows our most important asset, our people, to unlock their creativity and share that with others. The future of work is creative.â

âMost employees are still working with outdated technology and in places that are rooted in the past, which makes it difficult for them to work in new, creative ways,â said Bob OâDonnell, president, founder and chief analyst at TECHnalysis Research. âCreative Spaces were clearly designed to bridge the current gap between place and technology and to help creative work happen more naturally.â

Five initial Creative Spaces are on display now at the Steelcase WorkLife Center in New York City. Spaces include:

Focus Studio: Individual creative work requires alone time to focus and get into flow, while also allowing quick shifts to two-person collaboration. This is a place to let ideas incubate before sharing them with a large group, perfect for focused work with Microsoft Surface Book or Surface Pro 4.

Duo Studio: Working in pairs is an essential behavior of creativity. This space enables two people to co-create shoulder-to-shoulder, while also supporting individual work with Microsoft Surface Studio. It includes a lounge area to invite others in for a quick creative review with Surface Hub or to put your feet up and get away without going away.

Ideation Hub: A high-tech destination that encourages active participation and equal opportunity to contribute as people co-create, refine and share ideas with co-located or distributed teammates on Microsoft Surface Hub.

Maker Commons: Socializing ideas and rapid prototyping are essential parts of creativity. This space is designed to encourage quick switching between conversation, experimentation and concentration, ideal for a mix of Surface devices, such as Surface Hub and Surface Book.

Respite Room: Creative work requires many brain states, including the need to balance active group work with solitude and individual think time. This truly private room allows relaxed postures to support diffused attention.

âWe are facing a time of unprecedented change at work. Through this partnership we will bring together space and technology to help workers and organizations solve the workplace challenges they face today and in the future and ultimately perform their best at work,â explains Armbruster.

Steelcase: Microsoft Surface Hub Reseller
Select Steelcase dealers are authorized to resell Microsoft Surface Hub as a part of the Microsoft partner network beginning today in the United States and Canada, and in later Summer 2017 additional dealers in Germany and the United Kingdom are expected to be added to the program. The companies will announce additional markets in the coming months. As the spaces roll out in the Americas, Europe and Asia Pacific, the range of spaces will continue to expand and evolve.

Internet of Things
In the coming months, Steelcase expects to announce new technology-enabled office solutions built on Microsoft Azure IoT technology, which will provide companies with analytics that help improve workplaces and solutions to help employees find the best places to do diverse types of work within the office.

For more information on Creative Spaces and the partnership between Microsoft and Steelcase, visit www.steelcase.com/creativity or www.microsoft.com/en-us/devices/business/steelcase.

About Microsoft
Microsoft (Nasdaq âMSFTâ @Microsoft) is the leading platform and productivity company for the mobile-first, cloud-first world, and its mission is to empower every person and every organization on the planet to achieve more.

About Steelcase Inc.
For over 100 years, Steelcase Inc. has helped create great experiences for the world’s leading organizations. We demonstrate this through our family of brands – including Steelcase®, Coalesse®, Designtex® PolyVision® and Turnstone®. Together, they offer a comprehensive portfolio of architecture, furniture and technology products and services designed to unlock human promise and support social, economic and environmental sustainability. The company is globally accessible through a network of channels, including over 800 dealer locations. Steelcase is a global, industry-leading and publicly traded company with fiscal 2016 revenue of $3.1 billion.




BUZ INVESTORS VBIO Announces International Patent Filing - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality" or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids f

$VBIO Appoints Pharma Industry Veteran to Advance Cannabosides Regulatory Development

Appoints Pharma Industry Veteran to Advance Cannabosides Regulatory Development

BUZ INVESTORS  VBIO Appoints Pharma Industry Veteran Vitality Biopharma, Inc. ( OTCQB : VBIO ) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,

BUZ INVESTORS  VBIO Appoints Pharma Industry Veteran Vitality Biopharma, Inc. ( OTCQB : VBIO ) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced the appointment of Tracy Rockney, J.D., Co-Founder & Chief Operating Officer, OneSource Regulatory, to the position of Senior Regulatory Advisor.
Tracy Rockney, J.D. was formerly VP, Regulatory Affairs at AbbVie Inc. from May 2010 to May 2015, leading executive functions related to regulatory policy and intelligence, and from August 1993 to January 2005 she held positions of increasing responsibility with Pfizer (formerly Wyeth). From January 2005 to April 2010, she held positions with Shire Pharmaceuticals (“Shire”), including serving as Senior Director, Regulatory Affairs. This included responsibilities as Therapeutic Area Head for Shire’s Gastrointestinal Business Unit, Regulatory Advertising & Promotion and CMC.




OTHER STORIES BUZ TRADERS FOLLOW

VBIO Appoints Pharma Industry Veteran

In January 2007, during her tenure with Shire, Ms. Rockney led the regulatory team and negotiations with FDA for LIALDA™. The FDA approved Shire’s LIALDA™ with MMX® technology, which was the first once-daily oral formulation of mesalamines. Mesalamines are part of the drug class of aminosalicylates, now part of the clinical standard-of-care for treating inflammatory bowel disease. LIALDA™ was found to be effective in Phase 3 trials for inducing remission of active mild-to-moderate ulcerative colitis after eight weeks of treatment. LIALDA™ (also now marketed as Mezavant®) had U.S. sales in 2016 of $714 million, which increased by 16% relative to 2015 sales.

Vitality Biopharma has developed a new class of cannabinoid pharmaceuticals, known as cannabosides, which upon ingestion can enable the targeted delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Cannabosides could provide therapeutic benefits for inflammatory bowel disease while eliminating or reducing drug psychoactivity. Approximately 1.4 million Americans are affected by inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Most patients are diagnosed before age 30 and require life-long treatment.

“We’re very excited to have Tracy join our team, as a regulatory leader with a clear track record of innovation and success with development of new drugs for gastrointestinal disorders,” said Robert Brooke, Chief Executive Officer of Vitality Biopharma.

About Vitality Biopharma ( OTCQB : VBIO )
Vitality Biopharma is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. For more information, visit: www.vitality.bio. Follow us on Facebook, Twitter and LinkedIn.

Like up on FACEBOOK


Ebates Coupons and Cash Back



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




BUZ INVESTORS Ashburton Ships Zeolite Samples ASHBURTON VENTURES INC. (ABR-TSX:V) (ARB-FRANKFURT) ("Ashburton" or the "Company") is pleased to announce that zeolite has been shipped to BC Bud Depot (BCBD) Strain Development and Test Facility 1 Gulf Islands. Zeolite field trials are to commence according to ongoing crop

Ashburton Ships Zeolite Samples to BC Bud Depot for Research and Development of Zeolite in Marijuana Growing

Ashburton Ships Zeolite Samples to BC Bud Depot for Research and Development of Zeolite in Marijuana Growing

 

BUZ INVESTORS Ashburton Ships Zeolite Samples ASHBURTON VENTURES INC. <span data-recalc-dims=(ABR-TSX:V) (ARB-FRANKFURT) ("Ashburton" or the "Company") is pleased to announce that zeolite has been shipped to BC Bud Depot (BCBD) Strain Development and Test Facility 1 Gulf Islands. Zeolite field trials are to commence according to ongoing crop " width="300" height="188" srcset="https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/04/growhouse.png?resize=300%2C188 300w, https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/04/growhouse.png?resize=464%2C290 464w, https://i2.wp.com/investorsbuz.com/wp-content/uploads/2017/04/growhouse.png?w=501 501w" sizes="(max-width: 300px) 100vw, 300px" />

BUZ INVESTORS Ashburton Ships Zeolite Samples  ASHBURTON VENTURES INC. (ABR-TSX:V) (ARB-FRANKFURT)  (“Ashburton” or the “Company”) is pleased to announce that zeolite has been shipped to BC Bud Depot (BCBD) Strain Development and Test Facility 1 Gulf Islands. Zeolite field trials are to commence according to ongoing crop rotations in the 1,900-plant greenhouse facility, which features advanced light deprivation and supplementation systems to allow year-round cannabis cultivation.

Phase One is intended to determine if the filtration and aeration capacity of zeolite has potential to reduce soil-borne pests and illnesses by reducing non-beneficial bacteria, fungal spores and other microbes, insects and chemicals present in the growth medium. Testing will also monitor chemical composition and microbe biology of root zone growth media and liquid runoff. Comparative data will enumerate differences between zeolite-fortified groups and control groups consisting of standard coco coir and peat-based potting mixtures. Testing is designed to measure the impacts of zeolite’s filtration and retention capacity on the overall fertility and properties of cannabis growth media.




 

OTHER STORIES BUZ TRADERS FOLLOW

Ashburton Ships Zeolite Samples

Microbial analysis adhering to verifiable scientific practices and internationally recognized methods at MB Labs Ltd facilities in Saanich BC will measure growth media and liquid runoff for the presence of algae and protozoa, fungi, yeasts and bacteria. Dynamic Ecoystems Crop Protection of Salt Spring Island will conduct entomological inventories to detect estimated population variances of soil-born insect pests between control and zeolite test groups.

MB Labs will also test growth media and liquid runoff samples for a range of fertility factors including Nitrogen PH, (TKN), Phosphorus (P), Potassium (K), Organic Matter, Major and Minor Elements including Boron, Cadmium, Cobalt, Copper, Iron, Magnesium, Manganese, Molybdenum, Zinc, Conductivity (Salinity) and Carbon/Nitrogen Ratio. Of interest is whether zeolite confers upon growth media an increased capacity to retain beneficial nutrients and to act as a buffer against leaching and soil acidification.

The cannabis-certified MB Labs laboratory will also analyze finished marijuana samples for total potency, terpenes, flavonoids and contaminants following the field study.

“The scale of operations and growth methods deployed at our chosen test facilities will allow us to gather statistically relevant data pertaining to the root-zone fertility and ecology of cannabis grown with Z-1 zeolite quarried in Cache Creek BC,” stated Ashburton Ventures Inc. President David Gdanski. He continued, “BCBD growers are pleased to test a material with the potential to make cannabis cultivation a more successful enterprise.”

Ashburton Ventures Inc. is a Canadian-based junior exploration company focused on Canadian mineral projects in Quebec and British Columbia, Canada.  If you would like to be added the news release distribution please get in touch with us at info@ashburtonventures.com.

ON BEHALF OF THE BOARD

Signed “Michael England”

Michael England, CEO

FOR FURTHER INFORMATION PLEASE CONTACT:

Telephone: 1-604-683-3995; Toll Free: 1-888-945-4770; www.ashburtonventures.com

Like up on FACEBOOK


Ebates Coupons and Cash Back



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )

Buz Investors Alberta government workplace health and safety The Occupational Health and Safety (OHS) Innovation and Engagement Grants program will provide $667,000 for 33 projects during 2017.

Medicine Hat College development will better serve community

The province is investing $4.3 million to provide much-needed barrier-free access to college facilities for students and community members with disabilities.

Buz Investors Medicine Hat College development The East Campus Development project includes planning, design and renovation work to ensure students and members of the community with mobility issues

Buz Investors Medicine Hat College development The East Campus Development project includes planning, design and renovation work to ensure students and members of the community with mobility issues have access to gymnasium space. The project will replace the current aging wheelchair lift with a passenger elevator that can accommodate people as well as cargo, and update the gymnasium exit to include a wheelchair accessible ramp. The upgrades will create barrier free access and will also meet current building code requirements.





Medicine Hat College development

The project will also allow the college to upgrade sanitary infrastructure which is expected to reduce future maintenance costs. Sanitary sewer lines that service the college’s main building through the east campus are nearly 50 years old and require improvements.

“We’re working to make the lives of Albertans better by investing in capital projects that make college facilities and amenities accessible to all students and community members. These capital projects also create jobs and stimulate our economy.”

Marlin Schmidt, Minister of Advanced Education

“We are so pleased that the province has announced their support for this important preservation project. Upgrading the access to our gymnasium means that all members of our communities can now attend events in the gym with comfort, safety and dignity.”

Denise Henning, President of Medicine Hat College

“Access is an important issue for students so we were very pleased to hear the announcement supporting this upgrade. Right now, accessing the gym can feel like an ordeal for students with mobility issues – this project will eliminate that concern.”

Beth Lewis, Students’ Association President, Medicine Hat College

The Medicine Hat College project is one of 11 capital and planning projects for Alberta’s post-secondary system over the next four years. Government will invest $734 million in these projects, plus an additional $676 million in capital maintenance and renewal projects by 2020-21.


Ebates Coupons and Cash Back



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD)




Buz Investors Status Introduces CommitETH The development team behind Status, the leading mobile decentralized web browser for Ethereum, is pleased to introduce CommitETH,

Status Introduces CommitETH: A tool for enabling community driven development models

Extending GitHub to allow for incentivized contributions to open source projects

Buz Investors Status Introduces CommitETH The development team behind Status, the leading mobile decentralized web browser for Ethereum, is pleased to introduce CommitETH,

Buz Investors Status Introduces CommitETH The development team behind Status, the leading mobile decentralized web browser for Ethereum, is pleased to introduce CommitETH, a tool designed to foster open source software development. Our hope is that CommitETH will not only create stronger incentives for developers to get involved with open source projects, but also provide greater utility to app tokens, and provide token holders with direct say in the development direction of projects in the ecosystem.

As the web continues its shift towards decentralized business models powered by blockchains and protocol tokens, CommitETH will play a vital role in the evolution of their governance models and decision-making processes.



OTHER STORIES BUZ TRADERS FOLLOW

Status Introduces CommitETH

With CommitETH (https://commiteth.com/), holders of ETH, and soon ERC-20 tokens will be able to directly stake their holdings to drive the development of new features, the priority of bug fixes, and the implementation of integrations with other decentralized applications. This will have the impact of maximizing network effects and developer mindshare, expediting the rate of innovation and evolution across the Ethereum network as a whole.

At Status our mission is to make the decentralized web easy to access and interact with for all. The release of CommitETH marks the first step towards a decentralized organizational structure, by establishing a mechanism that will democratize our development, leading to a product created for the community by the community, something far more useful than we could build on our own.

The first release runs on the Ropsten Testnet, and developers and open source communities are encouraged to experiment and provide feedback.

Follow CommitETH

Homepage: https: https://commiteth.com/

Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )




Indie Game Development Studio, MetaGold Announces Cryptocurrency Crowdsale for Its MEG In-Game Currency

Indie Game Development Studio, MetaGold Announces Cryptocurrency Crowdsale for Its MEG In-Game Currency

Indie Game Development Studio, MetaGold Announces Cryptocurrency Crowdsale for Its MEG In-Game Currency

The MetaGold project has announced its upcoming crowdsale of MetaGold (MEG) cryptocurrency, an in-game currency for current and future game titles.

Indie Game Development Studio, MetaGold Announces Cryptocurrency Crowdsale for Its MEG In-Game Currency

March 2, 2017, Moscow, Russia – The Moscow-based indie game development studio, MetaGold is launching a crowdsale of its MetaGold (MEG) cryptocurrency. The soon to be launched crowdsale will involve custom ERC20 tokens based on the Ethereum blockchain.

The MEG cryptotokens, sold during the crowdsale will serve as an in-game currency for the games developed by MetaGold Studios. Subscribers to MetaGold crowdsale can use the tokens on the indie studio’s flagship War of Magi — a turn-based multiplayer card game and another upcoming cross-platform multiplayer adventure game, codenamed Project X.

OTHER STORIES BUZ TRADERS FOLLOW

 MetaGold Announces

 

With the MEG cryptotokens, gamers will be able to buy many collectible items, including custom skins, characters, booster packs, cards etc. All purchases made on the platform gets recorded on the Ethereum blockchain, enabling players to share, trade, sell or be a collector and safely store the items. The use of Ethereum blockchain also allows gamers and asset owners to verify their holdings at any time.

Assets owned by the players on MetaGold network are free from third-party intervention. It prevents others from seizing, deleting or modifying the assets or the markets on which they are exchanged.

The MetaGold team continues to develop both the current as well as new game titles. All the games developed by MetaGold will support and use MEG tokens as its native in-game currency. The MetaGold team will be creating a total of 8,000,000 MEG tokens, out of which 6,000,000 MEGs will be made available to the crowdsale participants. Rest of the 2,000,000 MEG tokens will follow the following distribution pattern:

a. 900,000 MEGs reserved for the founders of MetaGold
b. 800,000 MEGs for the platform’s advisors, partners, and other third-parties
c. 300,000 MEGs for campaigns and bounties.

The founders’ share of MetaGold tokens will be subject to a 6-month lock-in period, starting from the last day of the crowdsale.

MetaGold has already made its development roadmap for the year 2017 available on the website. It will soon announce the exact dates for the upcoming MEG crowdsale as well.

About War of the Magi

A creation of MetaGold Studios, War of the Magi is a turn-based multiplayer card game where players learn to master the magical skills and knowledge to graduate from being a young aspiring magician to a formidable magician. The game follows an exciting story campaign with 50 missions, complete with enchanting graphics and stunning visual effects. War of the Magi uses MEG cryptocurrency as its in-game currency.

About MetaGold

MetaGold is an independent game development studio based out of Moscow, Russia. The
three-member game development and distribution team has Michael Solomatin as the CEO/Senior Game Developer, Dmitry Kolyshko as the Web Developer/System Admin/Support, and Alexey Terenin as the Game Developer.

Learn more about MetaGold at – http://metagold.io/

Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results from Initial Human Observational Trials

$LXRP Announce Successful Cannabinoid Tablet Development

a) Pos(r)--md Pos(r)--sm W(1/1)--sm W(1/4) W(1/1)--md ie-7_Mstart(-310px)" data-reactid="24">
r) Bxz(bb) Fl(end) Fl(n)--sm Fl(n)--md M(a)--sm M(a)--md Maw(340px) Maw(640px)--sm Maw(640px)--md P(20px) Pb(0)--md Pb(0)--sm W(1/1)" data-reactid="27">
a) W(a)--sm W(0) W(a)--md" data-reactid="28">
r) Start(-150px) Start(a)--sm Start(a)--md W(a)--sm W(300px) W(a)--md" data-reactid="29">

36px) Fz(25px)--sm Fz(32px) Mb(17px)--sm Mb(20px) Mb(30px)--lg Ff($ff-primary) Lts($lspacing-md) Fw($fweight) Fsm($fsmoothing) Fsmw($fsmoothing) Fsmm($fsmoothing) Wow(bw)" data-reactid="3">Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results from Initial Human Observational Trials





 

a) Pos(r)--md Pos(r)--sm W(1/1)--sm W(1/4) W(1/1)--md ie-7_Mstart(-310px)" data-reactid="24">
r) Bxz(bb) Fl(end) Fl(n)--sm Fl(n)--md M(a)--sm M(a)--md Maw(340px) Maw(640px)--sm Maw(640px)--md P(20px) Pb(0)--md Pb(0)--sm W(1/1)" data-reactid="27">
a) W(a)--sm W(0) W(a)--md" data-reactid="28">
r) Start(-150px) Start(a)--sm Start(a)--md W(a)--sm W(300px) W(a)--md" data-reactid="29">
Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results from Initial Human Observational Trials
Lexaria Bioscience Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”) and NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, Frankfurt-1N9) are pleased to announce the successful development and initial trial of the industry’s first zero-sugar cannabinoid / pterostilbene edible tablet utilizing both Neutrisci’s and Lexaria’s proprietary and patented technologies.
bb) Mstart(0)--sm Mstart(0)--md Mstart(33.3%) P(20px) W(1/1)--sm W(1/1)--md ie-7_W(45%)" data-reactid="39">
r) M(a) Maw(600px) Maw(800px)--lg Mih(650px) Mih(0)--sm" data-reactid="40">
r) P(20px)--sm Pt(17px)--sm" data-reactid="2">
bw) Cl(start) Mb(20px) Ff($ff-secondary) Fz(15px) Lh(1.6)" data-reactid="4">

Neutrisci’s proprietary pterostilbene tablet formula was used to produce the world’s first pterostilbene / cannabidiol (CBD) rapid melt edible product offering the benefits of Lexaria’s patented CBD conjugation technology. The market-ready tablet offers improvements in taste, rapidity of onset, and strength of effect due to greater bioavailability, as had been originally hypothesized.

After trial batch formulation and manufacturing was completed, observational human tests supported that the user will experience the effects faster and last longer while utilizing smaller amounts of cannabinoid than competing products. The above noted benefits offer manufacturing efficiencies over competing products, thus potentially increasing comparative profitability.

NeutriSci and Lexaria confirm the companies expect to officially bind the JV agreement to market and commercialize a line of edible products using CBD derived from full spectrum hemp oil, which is federally legal in the United States, to be followed by tetrahydrocannabinol (THC) versions through distribution programs with both existing and planned new strategic partners. With successful first-stage formulation and human evaluation completed, the companies expect to conclude a working JV structure as soon as possible to financially capitalize on this unique opportunity.

“This joint venture is a demonstration of the rapid innovation occurring in the cannabis industry,” commented Chris Bunka, CEO of Lexaria Bioscience. “We are excited to work with NeutriSci; to combine both technology and form factor to develop healthy cannabinoid products to be sold within NeutriSci’s international distribution network.”

“We are very pleased with the results of this product formulation and observational trial, as the initial results have be invaluable in helping NeutriSci open dialogue with several of the world’s largest CBD manufactures and distributors,” commented Glen Rehman, President of NeutriSci International. “The idea to use our sublingual tablet and form factor to create a new line of zero-sugar and dose-controlled cannabinoid edible products will become a reality.”

Following the recent approvals for recreational use in certain US states, industry researchers have reported that the legal cannabis market could exceed $20 Billion by 2020.

About Lexaria

Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine, and other molecules.

www.lexariabioscience.com

About NeutriSci International Inc.

NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense, as well as men’s prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers.

Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )